Back to Journals » Patient Preference and Adherence » Volume 9

Shared decision-making in the People’s Republic of China: current status and future directions

Authors Huang R, Gionfriddo MR, Zhang L, Leppin A, Ting HH, Montori VM

Received 3 February 2015

Accepted for publication 5 May 2015

Published 6 August 2015 Volume 2015:9 Pages 1129—1141

DOI https://doi.org/10.2147/PPA.S82110

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Naifeng Liu

Rongchong Huang,1 Michael R Gionfriddo,2 Lizhi Zhang,3 Aaron L Leppin,2 Henry H Ting,4 Victor M Montori5

1Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, People’s Republic of China; 2Knowledge and Evaluation Research Unit and Mayo Graduate School, 3Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, 4New York-Presbyterian Hospital and Healthcare System, The University Hospital for Columbia and Cornell, New York, NY, 5Knowledge and Evaluation Research Unit and Division of Endocrinology, Mayo Clinic, Rochester, MN, USA

Background: Severe insufficiencies in the supply and inequities in the distribution of health care professionals, facilities, and services create conditions for limited quality of care and lack of trust – even violent conflict – between clinicians and patients in the People’s Republic of China. Alongside structural reform, shared decision-making (SDM) may help meet the needs and advance the goals of each patient. Little is known, however, about the realities and opportunities for SDM in the People’s Republic of China.
Methods: To identify reports of SDM in the People’s Republic of China, we used multiple sources, including: several databases, searched in English and Chinese, online journals, and clinical trial registries. In addition, we contacted experts in the field to identify any articles missed through our other search strategies. We included all trials and surveys reporting on SDM in Chinese patients. We summarized these studies by describing them with particular attention to reports of patient decisional preference and of the impact of SDM interventions on outcomes in Chinese patients.
Results: We identified five surveys examining patient preference for SDM and nine studies examining constructs related to SDM in Chinese patients, but none involving patients in Mainland China. We could not find any reports of development, testing, or implementation of SDM tools for patients in Mainland China.
Conclusion: The research on SDM in the People’s Republic of China is limited, with almost no direct evidence to inform clinical policies or implementation. Although multiple barriers are apparent, the value of implementing, testing, and disseminating effective SDM in the People’s Republic of China in terms of patient experience and outcomes demands urgent realization.

Keywords: shared decision-making, the People’s Republic of China, patient-centered care

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Assessing the feasibility and quality of shared decision making in China: evaluating a clinical encounter intervention for Chinese patients

Huang RC, Song XT, Wu J, Huang W, Leppin AL, Gionfriddo MR, Liu YX, Boehmer KR, Ting HH, Montori VM

Patient Preference and Adherence 2016, 10:2341-2350

Published Date: 14 November 2016

Readers of this article also read:

Immunosenescence: implications for vaccination programs in the elderly

Loukov D, Naidoo A, Bowdish DME

Vaccine: Development and Therapy 2015, 5:17-29

Published Date: 6 August 2015

Polyetherimide-grafted Fe3O4@SiO2 nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging

Li T, Shen X, Chen Y, Zhang C, Yan J, Yang H, Wu C, Zeng H, Liu Y

International Journal of Nanomedicine 2015, 10:4279-4291

Published Date: 2 July 2015

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010